Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"

被引：8
作者：
Mazurek, Michal [1 ,2 ]
Lip, Gregory Y. H. [1 ,3 ]
机构：
[1] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Silesian Med Univ, Silesian Ctr Heart Dis, Dept Cardiol Congenital Heart Dis & Electrotherap, Zabrze, Poland
[3] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
STROKE PREVENTION; DABIGATRAN; RISK; RIVAROXABAN; SAFETY; METAANALYSIS; WARFARIN; APIXABAN; TRIALS;
D O I：
10.1053/j.gastro.2017.02.027
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：932 / 934
页数：4
相关论文
共 20 条
[1]   Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study [J].
Abraham, Neena S. ;
Noseworthy, Peter A. ;
Yao, Xiaoxi ;
Sangaralingham, Lindsey R. ;
Shah, Nilay D. .
GASTROENTEROLOGY, 2017, 152 (05) :1014-+
[2]   Dabigatran use in elderly patients with atrial fibrillation [J].
Avgil-Tsadok, Meytal ;
Jackevicius-, Cynthia A. ;
Essebag, Vidal ;
Eisenberg, Mark J. ;
Rahme, Elham ;
Behlouli, Hassan ;
Pilote, Louise .
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) :152-160
[3]   Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice [J].
Beyer-Westendorf, Jan ;
Camm, A. John ;
Coleman, Craig I. ;
Tamayo, C. A. P. T. Sally .
THROMBOSIS AND HAEMOSTASIS, 2016, 116 :S13-S23
[4]   Dabigatran in real-world atrial fibrillation Meta-analysis of observational comparison studies with vitamin K antagonists [J].
Carmo, Joao ;
Costa, Francisco Moscoso ;
Ferreira, Jorge ;
Mendes, Miguel .
THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) :754-763
[5]   Moving the Tipping Point The Decision to Anticoagulate Patients With Atrial Fibrillation [J].
Eckman, Mark H. ;
Singer, Daniel E. ;
Rosand, Jonathan ;
Greenberg, Steven M. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (01) :14-21
[6]   Stroke prevention in atrial fibrillation [J].
Freedman, Ben ;
Potpara, Tatjana S. ;
Lip, Gregory Y. H. .
LANCET, 2016, 388 (10046) :806-817
[7]   Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation [J].
Graham, David J. ;
Reichman, Marsha E. ;
Wernecke, Michael ;
Hsueh, Hui ;
Izem, Rima ;
Southworth, Mary Ross ;
Wei, Yuqin ;
Liao, Jiemin ;
Goulding, Margie R. ;
Mott, Katrina ;
Chillarige, Yoganand ;
MaCurdy, Thomas E. ;
Worrall, Chris ;
Kelman, Jeffrey A. .
JAMA INTERNAL MEDICINE, 2016, 176 (11) :1662-1671
[8]   Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867
[9]   Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation [J].
Huisman, Menno V. ;
Lip, Gregory Y. H. ;
Diener, Hans C. ;
Dubner, Sergio J. ;
Halperin, Jonathan L. ;
Ma, Chang S. ;
Rothman, Kenneth J. ;
Teutsch, Christine ;
Zint, Kristina ;
Ackermann, Diana ;
Clemens, Andreas ;
Bartels, Dorothee B. .
AMERICAN HEART JOURNAL, 2014, 167 (03) :329-334
[10]   Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel [J].
Husted, Steen ;
de Caterina, Raffaele ;
Andreotti, Felicita ;
Arnesen, Harald ;
Bachmann, Fedor ;
Huber, Kurt ;
Jespersen, Jorgen ;
Kristensen, Steen Dalby ;
Lip, Gregory Y. H. ;
Morais, Joao ;
Rasmussen, Lars H. ;
Siegbahn, Agneta ;
Storey, Robert F. ;
Weitz, Jeffrey I. .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) :781-782
12